Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia

Current Stem Cell Research and Therapy

Volumn 5, Issue 4, 2010, Pages 379-386

  Basak, Pratima ^a   Chatterjee, Sumanta ^a   Das, Madhurima ^a   Das, Prosun ^a   Pereira, Jacintha Archana ^a   Kumar Dutta, Ranjan ^a   Chaklader, Malay ^a   Chaudhuri, Samaresh ^a   Law, Sujata ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Leukemia cellular phenotype stem cell stromal cell bone marrow

Indexed keywords

ATAXIN 1; CD123 ANTIGEN; CD44V ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CULTURE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; LEUKEMIA; LEUKEMIA CELL; LEUKEMOGENESIS; MALE; MICROENVIRONMENT; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; UPREGULATION;

ANIMALS; ANTIGENS, CD44; ANTIGENS, LY; BONE MARROW; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DISEASE PROGRESSION; ETHYLNITROSOUREA; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; IMMUNOPHENOTYPING; LEUKEMIA; MEMBRANE PROTEINS; MICE; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, CXCR4; TUMOR MICROENVIRONMENT;

EID: 78650034974     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488810793351677     Document Type: Article

References (49)

1. Sachs Leo. The control of hematopoiesis and Leukemia; From basic biology to the clinic. Proc Natl Acad Sci USA 1996; 93: 4742-9.
2. Evan GI, Vousden KH. Proliferation, Cell cycle and apoptosis in Cancer. Nature 2001; 411: 342-8.
3. Schofield R. The relationship between the spleen colony - forming cell and the haematopoietic stem cell. Blood Cells 1978; 4: 7-25.
4. Arai F. Regulation of hematopoietic stem cells and interactions with stem cell niche. J Oral Biosci 2006; 48(1): 22-9.
5. Lord B. Biology of the hematopoietic stem cell. In: Potten CS, Ed. Stem Cells. London: Academic Press 1997; pp. 401-22.
6. Li CL, Johnson GR. Murine hematopoietic stem and progenitor cells: I. Enrichment and Biological characterization. Blood 1995; 85: 1472-9.
7. Harrison DE, Stone M, Astle CM. Effects of transplantation on the primitive immunohematopoietic stem cell. J Exp Med 1990; 172: 431-7.
8. Harrison DE, Jordan CT, Zhong RK, Astle CM. Primitive hematopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Haematol 1993; 21: 206-19.
9. Zhao Y, Lin Y, Zhan Y, Yang G, Louie J, Harrison DE, Anderson WF. Murine Hematopoietic stem cell characterization and its regulation in BM transplantation. Blood 2000; 96(9): 3016-22.
10. Shizuru JA, Negrin RS, Weissman IL. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 2005; 56: 509-38.
11. Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the 'premetastatic niche': within bone and beyond. Cancer Metastatis Rev 2006; 25(4): 521-9.
12. Chantrain CF, Feron O, Marbaix E, DeClerck YV. Bone Marrow microenvironment and tumor progression. Cancer Microenviron 2008; 1(1): 23-35.
13. Nicola MH, Bizon R, Machado JJS, et al. Breast cancer micrometastases: Different interactions of carcinoma cells with normal and cancer patients' bone marrow stromata. Clin Exp Metastasis 2003; 20: 471-9.
14. Druckery H, Ivancovic S, Preussmann R. Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 1966; 210: 1378-9.
15. Koestner A, Swenberg JA, Wechsler W. Transplacental production with ethynitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. Am J Pathol 1971; 63(1): 37-56.
16. Law S, Maiti D, Palit A, Chaudhuri S. Role of biomodulators and involvement of protein tyrosine kinase on stem cell migration in normal and leukaemic mice. Immunol Lett 2003; 86: 287-90.
17. Law S, Maiti D, Palit A, Majumder D, Basu K, Chaudhuri S, Chaudhuri S. Facilitation of functional compartmentalization of bone marrow cells in leukemic mice by biological response modifiers: an immunotherapeutic approach. Immunol Lett 2001; 76(3): 145-52.
18. Yuan Y, Zhou L, Miyamoto T, et al. AML1-ETO expression is directly involved in the development of acute myeloid Leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 2001; 98: 10398-403.
19. Druckery H, Preussmann R, Ivankovic S, Schmahl D. Organtrope carcinogene wirukungen bei 65 verschiedenen N-nitrosoverbingdungen an BD-ratten. Z Krebsforsch 1967; 69: 103-201.
20. Magee PN, Barnes JM. The production of malignant primary hepatic tumors in the rat by feeding dimethylnitrosamine. Br J Cancer 1956; 10: 114-22.
21. Magee PN, Barnes JM. Carcinogenic nitroso compounds. Adv Cancer Res 1967, 10: 163-246.
22. Justice MJ, Noveroske JK, Weber JS, Zheng B, Bradley A. Mouse ENU mutagenesis. Hum Mol Genet 1999; 8(10): 1955-63.
23. Mitsiades CS, McMillin DW, Klippel S, et al. The role of the bone marrow microenvironment in the pathphysiology of myeloma and it's significance in the development of more effective therapies. Hematol Oncol Clin North Am 2007; 21: 1007-34.
24. Sun YX, Wang J, Shelburne CE, et al. Expression of CXCR4, CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003; 89: 462-73.
25. Geminder H, Sagi-Assif O, Goldberg L, et al. A possible role for CXCR4, its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001; 167: 4747-57.
26. Kozlow W, Guise TA. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 2005; 10: 169-80.
27. Strahm B, Durbin AD, Sexsmith E, Malkin D. The CXCR4- SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma. Clin Exp Metastasis 2008; 25: 1-10.
28. Liu J, Jiang G. CD. CD44 and hematologic malignancies. Cell Mol Immunol 2006; 3: 359-65.
29. Nemzek JA, Bolgos GL, Williams BA, Remick DG. Differences in normal values for murine white blood cell counts and other haematological parameters based on sampling site. Inflamm Res 2001; 50(10): 523-7.
30. Lewis SM, Bain BJ, Bates I. Dacie and Lewis Practical Haematology 10th ed. Elsevier 2007; pp. 61-5.
31. Chatterjee S, Basak P, Das M, et al. Kinetic Impairment of Haemopoietic Stem Cells in Experimentally Induced Leukemia and Aplastic Anemia An Inverse Correlation. J Stem Cells 2009; 4(3): 179-189.
32. Testa NG, Molineux G. Haemopoiesis. A practical approach. New York, NY: Oxford University Press; 1993.
33. Hubin F, Humblet C, Belaid Z, et al. Murine bone marrow stromal cells sustain in vivo the survival of Hematopoietic stem cells and the Granulopoietic differentiation of more mature progenitors. Stem Cells 2005; 23: 1626-33.
34. Hu ZB, Ma W, Uphoff CC, Metge K, Gignac SM, Drexler HG. Myeloperoxidase: expression and modulation in a large panel of human leukemia - lymphoma cell lines. Blood 1993; 82; 1599-1607.
35. Ferrari S, Mariano MT, Tagliafico E, et al. Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. Blood 1988; 72: 873-6.
36. Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Prot 2009; 4(1): 102-6.
37. Ringden O, Le Blanc K. Allogenic hematopoietic stem cell transplantation: state of the art and new perspectives. APMIS 2005; 113: 813-30.
38. Mendes SC, Robin C, Dzierzak E. Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny. Development 2005; 132: 1127-36.
39. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
40. Chaudhuri S, Law S. Stem cells and frontiers of therapeutic Advances in cancer. J Exp Clin Cancer Res 2005; 24: 165-73.
41. Zou GM. Cancer stem cells in leukemia, recent advances. J Cell Physiol 2007; 213(2): 440-4.
42. Jordan CT, Upchurch D, Szilvassy SJ, et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 2000; 14: 1777-84.
43. Huang S, Chen Z, Yu JF, Young D, Bashey A, Ho AD, Law P. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic Cells from different tissues. Stem Cells 1999; 17: 265-72
44. Burger JA, Peled A. CXCR4 antagonists: targeting the microenvironment in leukemia and other Cancers. Leukemia 2009; 23: 43-52.
45. Burger JA, Burkle A. The CXCR4 chemokine receptor in acute and chorine leukemia: a marrow homing receptor and potential therapeutic target. Br J Haematol 2007; 137: 288-96.
46. Alsayed Y, Ngo H, Runnels J, et al. Mechanisms of regulation of CXCR4/ SDF-1 (CXCL12)- dependent migration and homing in multiple myeloma. Blood 2007; 109: 2708-17.
47. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107: 1761-7.
48. Lazennec G, Jorgensen C. Concise Review: Adult multippotent stromal cells and cancer: risk or benefit? Stem Cells 2008; 26: 1387-94.
49. Lewinsohn DM, Nagler A, Ginzton N, Greenberg P, Butcher EC. Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 1990; 75: 589-95.